Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FV583
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,692
Award facts
- Contract value 100% obligated
- $57,692.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $57,692.09 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 milligram dose injections on January 15, 2026, with completion expected by January 16, 2026. This delivery order is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical supplies across multiple therapeutic domains. Cosentyx is a biologic immunosuppressant used to treat various autoimmune conditions and is part of the broader range of pharmaceutical products that AmerisourceBergen supplies to support Department of Defense medical operations and the Defense Health Agency.
Quick answers
Who was awarded contract SPE2DR26FV583?
SPE2DR26FV583 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FV583 worth?
The government has obligated $57,692 on SPE2DR26FV583.
Is contract SPE2DR26FV583 an order under another contract?
Yes. SPE2DR26FV583 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV583 competed?
The extent of competition for SPE2DR26FV583 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award